ConditionPancreatic Cyst
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18+
SponsorM.D. Anderson Cancer Center
About this trial
To learn if Hyperpolarized C-Pyruvate Magnetic Resonance (HP-MR) Spectroscopic Imaging can help doctors detect low-risk (benign) and high-risk (malignant) cysts.
Eligibility criteria
Qualifiers
Patients ≥ 18 years old. Patients under 18 are excluded due to their potential inability to understand and consent independently to the methods required for the study drug use and its potential risks and benefits.
Patients with pancreatic cyst/s
Patients who will undergo surgical resection (or cyst wall biopsy) of pancreatic cysts
Patients able to understand and willing to sign a written informed consent document
Disqualifiers
Contraindication to MRI
Electrically, magnetically, or mechanically activated implants that would preclude MRI
Allergy to Gadavist IV contrast
History of cardiac arrhythmias
Trial design
Treatments tested in this trial
- Hyperpolarized 13-C-pyruvate
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov